IADR Abstract Archives

In vivo Examination of Bulk-fill Composites After 2 Years

Objectives: The aim of this study was to investigate the clinical performance of direct bulk-fill composites compared to a conventional composite over a period of 2 years.
Methods: A low-viscosity (SDR), a high-viscosity bulk-fill (Tetric EvoCeram BulkFill) and a conventional nanohybrid composite (Tetric EvoCeram) were randomly assigned and placed in different layer thicknesses up to 4 mm in 160 class-II-cavities in 94 patients. The restorations were clinically examined at basline (n=160;T0), after 12 (n=150;T1) and 24 months (n=148;T2). The restorations were evaluated according to eight selected FDI criteria (surface luster, surface staining, marginal staining, color match and translucency, esthetic anatomical form, fracture of material and retention, margin adaptation, postoperative (hyper-) sensitivity and tooth vitality), where 1 represents the best and 5 the worst rating. Restorations that could be repaired were classified as survive. In case of a complete loss of the restoration or irreversible pulpitic symptoms the restoration was rated as failure. Data was statistically analyzed with a Pearson’s chi-squared- and Kruskal-Wallis-test using SPSS (IMB SPSS Statistics 25.0).
Results: The materials investigated showed no significant differences regarding the FDI criteria scores and failure rate during the entire follow-up. At T1, 7 failures and at T2 a total of 8 failures were observed (table). After 2 years, Tetric EvoCeram BulkFill with a 4mm layer thickness and SDR in combination with Tetric EvoCeram BulkFill with a 2mm layer thickness exhibited a non-significant tendency towards an increased hypersensitivity (FDI score 5) as compared to the reference material Tetric EvoCeram and Tetric EvoCeram BulkFill of a 2mm layer thickness (p=0.051; Kruskal-Wallis-test).
Conclusions: The clinical stability of bulk-fill materials in layers up to 4 mm is comparable to nanohybrid composites after 2 years.
Division: IADR/AADR/CADR General Session
Meeting: 2020 IADR/AADR/CADR General Session (Washington, D.C., USA)
Location: Washington, D.C., USA
Year: 2020
Final Presentation ID: 1387
Abstract Category|Abstract Category(s): Dental Materials 8: Clinical Trials
Authors
  • Hoffmann, Lea  ( University Hospital, LMU Munich , Munich , Germany )
  • Cornelia, Neuerer  ( University Hospital, LMU Munich , Munich , Germany )
  • Katrin, Heck  ( University Hospital, LMU Munich , Munich , Germany )
  • Kunzelmann, Karl-heinz  ( University of Munich , Munchen, , Germany )
  • Financial Interest Disclosure: NONE
    SESSION INFORMATION
    Poster Session
    Clinical Trials
    TABLES
    Events after 12- and 24-month follow-up of the materials investigated
    MaterialT1(n)EventsSurvival/failureT2(n)EventsSurvival/failure
    TetCER20-Failure0--
    TetBF21Loosened fillingFailure1Loosened fillingFailure
    SDR4+TetBF23PulpitisFailure1Pulpitis and extractionFailure
    2PulpitisFailure
    2Repair requiredSurvive
    TetBF41Filling lossFailure1Filling lossFailure
    2PulpitisFailure2PulpitisFailure
    1PulpitisFailure
    Total7Events10Events
    7Failure8Failure
    4.5Failure rate in %5.4Failure rate in %
    4.5AFR rate in %2.7AFR rate in %
    The term event summarizes all the incidences that required further treatments such as repairs, new filling, root canal treatments or tooth extractions. Events written in cursive at T2 count as subsequent events from T1. AFR= Annual failure rate; TetCERM2= Tetric EvoCeram 2mm layer thickness, TetBF2= Tetric EvoCeram BulkFill 2mm layer thickness, SDR4 + TetBF2 = SDR 4 mm layer thickness + Tetric EvoCeram Bulkfill 2 mm layer thickness, TetBF4= Tetric EvoCeram Bulk fill 2mm layer thickness